Results 51 to 60 of about 742,879 (208)

Survival outcomes of laparoscopic versus open total gastrectomy with nodal dissection for gastric cancer in a high‐volume Japanese center: A propensity score‐matched analysis

Annals of Gastroenterological Surgery, 2023
Aim To compare the survival outcomes of laparoscopic total gastrectomy (LTG) with those of open total gastrectomy (OTG) in gastric cancer. Methods Using an in‐house database, this single‐center study reviewed clinical data for patients who underwent ...
Takahiro Kinoshita, Eigo Akimoto, Masahiro Yura, Mitsumasa Yoshida   +3 more
doaj   +1 more source

Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori. [PDF]

, 2018
New Zealand Māori have a considerably higher incidence of gastric cancer compared to non-Māori, and are one of the few populations worldwide with a higher prevalence of diffuse-type disease.
Cheng, Soo, Day, Robert, Ellison-Loschmann, Lis, Gray, Michelle, Guilford, Parry, Hakkaart, Christopher, Harawira, Pauline, Koea, Jonathan, Pearce, Neil, Sporle, Andrew, Whaanga, Tracey   +10 more
core   +1 more source

Follow-up after curative resection for gastric cancer. Is it time to tailor it? [PDF]

, 2017
There is still no consensus on the follow-up frequency and regimen after curative resection for gastric cancer. Moreover, controversy exists regarding the utility of follow-up in improving survival, and the recommendations of experts and societies vary ...
Antolino, L, Aurello, P, D'Angelo, F, Giulitti, D, Petrucciani, N, Ramacciato, G.   +5 more
core   +1 more source

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts [PDF]

, 2001
BACKGROUND: The magnitude of the association between Helicobacter pylori and incidence of gastric cancer is unclear. H pylori infection and the circulating antibody response can be lost with development of cancer; thus retrospective studies are ...
Aase, S., Aromaa, A., Berglund, G., Blaser, M.J., Chen, C.J., Dawsey, S.M., Floren, C.H., Forman, D., Forsgren, A., Friedman, G.D., Hansen, S., Heinonen, O.P., Jellum, E., Knekt, P., Kosunen, T.U., Kurata, J.H., Law, M., Limberg, P.J., Lin, J.T., Mark, S.D., Melby, K.K., Nomura, A., Ozasa, K., Parsonnet, J., Qiao, Y.L., Ross, R., Siman, J.H., Stemmermann, G.N., Taylor, P.R., Tulinius, H., Varghese, C., Virtamo, J., Vollset, S.E., Wald, N.J., Watanabe, Y., Webb, P.M., Yu, M., Yuan, J.M.   +37 more
core   +1 more source

Robotically assisted total gastrectomy for lymphadenopathy after long-term follow-up for multiple type 1 gastric neuroendocrine tumor (NET): a case report

Surgical Case Reports, 2023
Background Type 1 gastric neuroendrine tumor (NET) is usually associated with chronic atrophic gastritis and forms multiple lesions. While most cases of type 1 gastric NET are generally slowly growing, some develop regional lymph node metastases even ...
Nozomi Funatsu, Kentaro Hara, Maki Takagi, Atsushi Onodera, Kohdai Ueno, Kazuya Endo, Haruhiko Cho   +6 more
doaj   +1 more source

Gastric inflammatory myofibroblastic tumor: a case report

Surgical Case Reports
Background Inflammatory myofibroblastic tumor (IMT) of the stomach is an uncommon mesenchymal neoplasm. We present a case of gastric submucosal tumor (SMT) where the final diagnosis was IMT.
Taku Hattori, Yutaka Tanizawa, Tadakazu Shimoda, Yusuke Koseki, Kenichiro Furukawa, Keiichi Fujiya, Daisuke Aizawa, Takashi Sugino, Masanori Terashima, Etsuro Bando   +9 more
doaj   +1 more source

Experiences of multidisciplinary gastric cancer treatment at the National Cancer Center, Korea [PDF]

Korean Journal of Clinical Oncology, 2013
Multidisciplinary treatment (MDT) is considered to be beneficial for patients undergoing complex treatments for cancer. The efforts of MDT led to the initiation of nowadays well known trials in gastroesophageal cancer treatment.
Daniel Reim, Bang Wool Eom, Young-Woo Kim   +2 more
doaj   +1 more source

FGFR2 amplification in colorectal adenocarcinoma [PDF]

, 2017
FGFR2 is recurrently amplified in 5% of gastric cancers and 1%–4% of breast cancers; however, this molecular alteration has never been reported in a primary colorectal cancer specimen.
Carter, Jamal H, Cottrell, Catherine E, Duncavage, Eric J, Heusel, Jonathan W, Lamp, Stephen, McNulty, Samantha N, Vigh-Conrad, Katinka A   +6 more
core   +2 more sources

microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer

BMC Cancer, 2018
Background It is urgent to find some biochemical markers for predicting the radiochemotherapy sensitivity. microRNAs have a huge potential as a predictive biomarker in gastric cancer.
Xiaowen Liu, Hong Cai, Weiqi Sheng, Hua Huang, Ziwen Long, Yanong Wang   +5 more
doaj   +1 more source

Report of two patients in whom comparisons of the somatic mutation profile were useful for the diagnosis of metastatic tumors

Surgical Case Reports, 2022
Background When a patient has multiple tumors in different organs, it is very important to identify whether the tumors are multiple cancers or metastasis from one tumor in order to establish an optimal treatment strategy.
Kenichiro Furukawa, Keiichi Hatakeyama, Masanori Terashima, Keiichi Fujiya, Yutaka Tanizawa, Etsuro Bando, Takashi Sugino, Kenichi Urakami, Tateaki Naito, Hiroyasu Kagawa, Ken Yamaguchi   +10 more
doaj   +1 more source